REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-FTSE 100 helped by weak pound; New COVID-19 restrictions hit consumer stocks

Wed, 09th Sep 2020 09:59

* AstraZeneca pauses trials of coronavirus vaccine

* England bans gatherings of more than six people

* No-deal Brexit fears send pound to six-week low
(Adds details, updates to market close)

By Shashank Nayar and Ambar Warrick

Sept 9 (Reuters) - London's blue-chip index ended higher on
Wednesday as weakness in the pound looked to benefit major
exporters, while the mid-cap index was held back by consumer
stocks on fears of new restrictions on social activity.

The FTSE 100 ended 1.4% higher as uncertainty over
Brexit talks weighed on the pound. Stocks such as British
American Tobacco and Unilever, which make a
bulk of their revenue overseas, were the biggest boosts to the
index.

The midcap index ended 0.2% lower, with consumer
discretionary stocks weighing the most as Prime Minister Boris
Johnson announced new restrictions on social gatherings in
England to tackle a surge in COVID-19 cases.

Pub and restaurant owners including J D Wetherspoon Plc
, Marston's Plc and Restaurant Group Plc
fell between 8% and 11%, while the domestic travel and leisure
index lost 1.4%.

"The new social restrictions have led to some panic selling,
especially in some restaurant and pub stocks, with the
possibility of further downfall if more draconian restrictions
are imposed," said Keith Temperton, a sales trader at Forte
Securities.

AstraZeneca Plc recovered from initial losses,
ending marginally higher on a report that it could resume trials
for its experimental coronavirus vaccine next week. The firm had
paused trials of the vaccine after an unexplained illness in a
participant.

Its peer Glaxosmithkline, which is also developing a
vaccine, rose 2.7%.

Hopes for vaccines and treatments to address the pandemic
have helped lift global equity benchmarks after a crash earlier
this year.

But British stocks have lagged their peers in the developed
world as resurgent infections and middling economic data cut
short an initial bounce from March lows.

In company news, shares in Britain's biggest domestic bank
Lloyds were flat as it said it was making 865
redundancies, with lenders resuming cost-cutting measures to
ride out the impact of the pandemic.
(Reporting by Shashank Nayar in Bengaluru; Editing by Saumyadeb
Chakrabarty, Mark Potter and Alexandra Hudson)

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.